![]() | Amgen shares sink despite quarterly beat, FDA places obesity drug on clinical hold Süre: 0:39 | Boyut: 1.49 MB |
![]() | Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond Süre: 3:42 | Boyut: 8.47 MB |
![]() | Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared Holz Süre: 4:31 | Boyut: 10.34 MB |
![]() | Seagen sinks on concerns of heightened antitrust scrutiny of drug industry Süre: 2:18 | Boyut: 5.26 MB |